Further evaluation of SPHK1 levels in paraffin-embedded, archived clinical tumor specimens of NSCLC cases, using IHC analysis with an antibody against human SPHK1, revealed significantly elevated SPHK1 levels in NSCLC cases compared to the matched adjacent tissue (Figure 1D). This evidence concerns the gene SPHK1 and non-small cell lung carcinoma.